Wegovy and Ozempic are both semaglutide weight loss medications, but they’re prescribed differently based on who qualifies.

Novo Nordisk A/S' Q1 earnings reveal strong growth in semaglutide-driven sales despite a slight revenue miss. Learn more ...

In a large study of diabetes, heart failure, or chronic kidney disease patients on renin-angiotensin-aldosterone system (RAAS ...

A Maryland man has filed a lawsuit against the manufacturers of Ozempic, alleging that his use of the drug led to him ...

Data across obesity, cardiovascular disease, MASH, type 2 diabetes, as well as advances in obesity-related care to be presented at ECO 2025 - covering burden, and the value of treatment and prevention ...

A Howard County man is suing Novo Nordisk, alleging Ozempic caused him to go blind after using the drug to treat diabetes.

Prior to starting the trial, the participants also had moderate to high levels of scar tissue in the liver, known as stage 2 ...

Related FDA warns of fake Ozempic Type 2 diabetes injection drugs Evidence grows that Ozempic can curb alcoholism GLP-1 medications show promise in slowing kidney disease progression MASH occurs ...

By Dani Blum I’ve reported on Ozempic since 2022 ... Patients may need a liver transplant, or can die from the disease. Novo Nordisk has asked the Food and Drug Administration to approve ...

In his suit, Todd Engel, of Howard County, accused Novo Nordisk Inc. and 10 other ... for the treatment of diabetes and chronic kidney disease. However, it is often prescribed or used for weight ...

executive vice president of Product & Portfolio Strategy at Novo Nordisk. "Our investment into the understanding and treatment of obesity continues to reveal new insights, with semaglutide showing its ...